search

All clinical trials

Results 8171-8180 of 470744

Deep Sclerectomy Versus Trabeculectomy in Normal Tension Glaucoma

Normal Tension Glaucoma

The purpose of this study is to assess whether deep sclerectomy is as effective in lowering intraocular pressure (IOP) as trabeculectomy in patients with normal tension glaucoma.

Recruiting18 enrollment criteria

Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B-NHL After Failure of Autologous...

Non-Hodgkin's Lymphoma

This is a phase I, single center study to assess the efficacy and safety of ThisCART19A in adult with Non-Hodgkins Lymphoma in China.

Recruiting19 enrollment criteria

Addressing Antihypertensive Medication Adherence Through EHR-enabled Teamlets in Primary Care

Blood PressureMedication Adherence

The study team will conduct a cluster randomized control trial in up to 22 NYU primary care practices to assess the effectiveness and implementation of the multicomponent intervention on medication adherence and blood pressure control for patients who are non-adherent to antihypertensive medications.

Recruiting14 enrollment criteria

A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT

Pigmented Villonodular SynovitisTGCT1 more

AMB-051-07 is an Open-Label, Adaptive, Dose-Ranging Study with Long-Term Extension which will enroll approximately 48 adult subjects with TGCT for IA doses over a 24-week dosing period (Part 1) with a Part 2 OLE of 6 treatment and/or observational cycles of 12 weeks each followed by 12 weeks of follow-up.

Recruiting22 enrollment criteria

Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians...

Type 2 DiabetesCardiovascular Complication1 more

The Effects and Safety of Diabetic GUideline Algorithm Implementation in the Community (GUARD-Community) study is a 2-arm, cluster-randomized control trial to evaluate the effect and safety of guideline algorithm intervention performed by primary care physicians on cardiovascular and renal outcomes in elderly patients with high risk in community.

Recruiting17 enrollment criteria

Atomoxetine and DAW2022 on OSA Severity

Obstructive Sleep Apnea

Obstructive sleep apnea (OSA) is common and has major health implications but treatment options are limited. In previous research atomoxetine and oxybutynin showed promising effect at reducing OSA severity, however they reduced arousal threshold, one of the key traits responsible for OSA. Since oxybutynin was used mainly as a hypnotic, but it is burdened by several anti-cholinergic side effects, DAW2020, a hypnotic which prolonged the total sleep time in a previous trial in OSA patients, could be a better candidate to associate with atomoxetine.

Recruiting12 enrollment criteria

Evaluate the Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With R/R B-ALL

B-ALL

This is an open label, phase I study to assess the safety, efficacy and pharmacokinetics of ThisCART19A in patients with relapsed and refractory acute B-cell leukemia

Recruiting34 enrollment criteria

Evaluate the Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With MRD+ B-ALL

B-ALL

This is an open label, phase I study to assess the safety, efficacy and pharmacokinetics of ThisCART19A in patients with MRD+ B-ALL

Recruiting22 enrollment criteria

Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection...

Myocardial InfarctionAcute2 more

This is a Phase 2, multicenter, randomized, parallel, 3-arm, placebo-controlled study to assess efficacy and safety of CDR132L in patients with reduced Left Ventricular Ejection Fraction (LVEF) (≤ 45%) after myocardial infarction (MI). This study consists of a screening period (to occur at least 3 days after MI diagnosis), a 6-month double-blind period, and a 6-month extension period with the End of Study (EOS) Visit at Day 360/Month 12. Two dosages of CDR132L will be tested against placebo on their effects on patients, who just had a heart attack in addition to standard care. The aim of the study is to show that CDR132L is safe and effective to improve heart failure in such patients.

Recruiting23 enrollment criteria

A Study to Assess the Safety and Efficacy of Nitric Oxide Injection Into Unresectable Solid Primary...

Cancer

This is a Phase 1, open-label, dose-escalation and dose-expansion study comprised of a screening period, a single treatment session, and follow-up period of up to Day 60±5 days post-treatment.

Recruiting15 enrollment criteria
1...817818819...47075